SR One
Transatlantic biotechnology venture capital firm partnering with scientific founders to translate innovative research into new medicines. Takes a back-and-build approach across the development continuum in life sciences with offices on the US West Coast and in London.
Investment Stages
Investment Focus
BioTechTherapeuticsOncologyImmunologyRare DiseasesCardiometabolicNeuropsychiatryGene TherapyRNA Therapeutics
Founded
2020
Investment Themes
Bio/Health-Focused
Multi-Stage
Thesis-Driven
Transatlantic
Operator-Led
You're viewing 1 investor
Go from one investor to the complete database.
Every investor · Stages · Sectors · Locations · CSV + Excel
Get the Complete Investor Database →Similar Investors
Avego BioScience Capital
Series A · Series B · Series C
Alpharetta · New York
Frazier Life Sciences
Seed · Series A · Series B
Palo Alto · Seattle +2
Omega Funds
Seed · Series A · Series B
Boston · Geneva
Atlas Venture
Seed · Series A · Series B
Cambridge
Westlake BioPartners
Seed · Series A · Series B
Westlake Village
Access Biotechnology
Seed · Series A · Series B
New York · London
Related Investor Lists
Still just 1 investor
Get the complete database — not just this profile.
Every investor · Stages · Sectors · Locations · CSV + Excel
Get the Complete Investor Database →